🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Sure, organizations realize AI can be a path to better business outcomes, but how long does it really take to see actual value from AI investments? We'll close out #SASInnovate on May 9 by focusing on acceleration, joined by CIO of Parexel on main stage. 2.sas.com/60182vCSM

Parexel was a proud sponsor at the Triangle Take Steps fundraiser, presented by Duke GI and the Crohn's & Colitis Foundation. Our team showed up to support patients and the research that could change the lives of those living with inflammatory bowel disease (IBD). #PatientsFirst #TakeSteps

What unites us? We asked the team!  ➡️ Discover what drives our shared passion and commitment to advancing healthcare and improving patient outcomes. Join us: pxl.careers/6jk #ParexelCareers #ClinicalResearch

💪Santino Tin began at Parexel as a Project Specialist and has climbed the ranks in Clinical Operations, embodying our #PatientsFirst promise every step of the way. Learn why he chose Parexel, about his hobbies and how you can join him in changing patients' lives. #ParexelCareers

📢 The deadline for Parexel Academy's Summer Virtual Postgraduate Certificate Program (vPGC) is fast approaching! This 6-month program—now updated to prepare you for changes in the ICH-GCP guidelines—will help you stay ahead.📅Applications close on Wednesday, May 7, so apply now!

At the Advarra #Onsemble2025 Conference, Chief Patient Officer, Stacy Hurt, delivered a powerful keynote sharing her journey as a🔹Caregiver🔹Stage IV colorectal cancer survivor🔹Industry executive🔹Patient engagement expert🔹Patient advocate.🎙️"Now is the time to be bold."

We're making headlines...Parexel's Peyton Howell and Sanjay Vyas shared insights with Scrip and The Economic Times about #AI-driven efficiencies, patient data and challenges for sponsors in India.📖Swipe for highlights and tap to read the full articles:

CEO Peyton Howell joined leaders at USAIC's Biopharma & Healthcare Summit to share insights on India's regulatory landscape and opportunities for the clinical trial sector. #ClinicalResearch #India #USAIC25

Once Parexel, always Parexel.✨Last week, more than 75 former Boston-based colleagues gathered to network and make connections at the annual #ParexelAlumni Community event. CEO Peyton Howell shared exciting updates and Founder Josef von Rickenbach spoke to our enduring community.

Jonathan Shough, CIO at Parexel: "At the end of the day, we’re delivering a data pack that says "we believe this protocol, and we believe this therapy or this treatment is actually going to do what it’s going to do because our SAS data sets help prove it."" #SASInnovate

Our Early Phase Clinical Units conduct first-in-human trials generating high-quality data, promoting patient inclusion and bringing new treatments to those in need. Click to explore opportunities in: Clinical🔹 Project Management🔹 Laboratory🔹 Medical🔹 Recruitment🔹Pharmacy.

Congratulations to Teri Karcher on her recognition as a 2025 HBA Luminary! Thank you, Teri, for your work that advances treatments for patients and is inspiring future leaders! #HBAWOTY25

Parexel today launched “Optimizing the clinical research workforce: An industry analysis by Parexel,” a report aimed at understanding the role that culture, key skill sets and talent delivery models play in driving innovation in clinical development. Read the release. 📰

As the NIH embraces human-based research technologies, Parexel guides clients using expertise rooted in real-world experience. In PharmaVoice, our Mwango Kashoki shares how strides in non-animal testing are meeting regulatory progress—and how sponsors can stay ahead.📖

On #ICTDay, we celebrate the dedicated professionals behind every breakthrough and patient success. Our new 'Optimizing the Clinical Trials Workforce' report explores workforce trends so that we can best nurture top talent and empower our people to drive progress.

In letter to Applied Clinical Trials, our Chief Patient Officer, Stacy Hurt, states that embedding the patient voice at each stage of drug development is not only moral, but drives efficiency, recruitment and real-world relevance. Learn how patient engagement can be a key differentiator.📰

Congrats to our CEO, Peyton Howell, on being honored with the "Clinical Trials Day Award" from Walgreens! Peyton was recognized at the Walgreens #ClinicalTrialsDay event for her commitment to advancing research innovation and breaking down barriers to study participation.

Rescue studies are challenging—but with the right approach, they’re entirely manageable. At OCT Europe, Parexel's Suzanne McNally shared how her team supports sponsors through complex trial transitions with speed, agility and strategic foresight.

Congratulations to the 10 Parexel colleagues who represented Parexel with distinction and earned Silver Awards in the 2025 PharmaTimes International Clinical Researcher of the Year competition in London!👏#PTINTCR #PharmaTimes

Parexel today announced the company will present five posters highlighting key research at the 2025 ASCO Annual Meeting May 30-June 3 in Chicago. Newly appointed Chief Medical Officer, Dr. Charlotte Moser, will attend along with the company’s expert Oncology and Hematology team.